Skip to content

A Study on the Application of Linaclotide Combined with Polyethylene Glycol for Bowel Preparation Before Colonoscopy in Patients with Risk Factors for Inadequate Bowel Preparation

A Study on the Application of Linaclotide Combined with Polyethylene Glycol for Bowel Preparation Before Colonoscopy in Patients with Risk Factors for Inadequate Bowel Preparation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099879
Enrollment
Unknown
Registered
2025-03-31
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Group A/Group B/Group C/Group D:None

Sponsors

Liaoning Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
70 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Advanced age (> 70 years old); 2. Constipation (chronic constipation is defined as having less than three bowel movements per week, with or without the use of laxatives); 3. Diabetes mellitus (with comorbidities); 4. Obesity (BMI>=25Kg/m^2); 5. Patients and their families have given informed consent to the purpose and content of this study and voluntarily signed the informed consent form

Exclusion criteria

Exclusion criteria: 1. History of acute myocardial infarction (within 6 months), severe heart failure (New York class II-IV), chronic renal failure (stage 2-5) or mental disorder; 2. History of colorectal resection; 3. History of aspirin, warfarin or other anticoagulant drug use, or history of coagulation disorder; 4. History of taking any medications, proton pump inhibitors, non-steroidal anti-inflammatory drugs (NSAIDs) or antibiotics that may affect gastrointestinal motility (within the past 4 weeks), probiotics (within the last 2 weeks); Have taken linaclotide within 5.7 days or are known to be allergic to linaclotide; 6. Patients who are pregnant or breastfeeding during the study; 7. Patients with inflammatory bowel disease, frequent diarrhea, severe gastroparesis, intestinal perforation or intestinal obstruction; 8. Patients who cannot complete the whole course of colonoscopy; 9. Patients who have not provided written informed consent.

Design outcomes

Primary

MeasureTime frame
Adequate Bowel Preparation Rate;

Secondary

MeasureTime frame
Insertion time;Withdrawal time;Polyp Detection Rate ;Adenoma Detection Rate ;Adverse Reaction Rate;Compliance;Diminutive Polyp Detection Rate ;

Countries

China

Contacts

Public ContactYao Yuan

Liaoning Provincial People's Hospital

CXJ18447441168@163.com+86 177 0248 7507

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026